Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Stock Forecast

Stock Price Forecast

The 13 analysts that cover Rhythm Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $88.77, which forecasts a -0.66% decrease in the stock price over the next year. The lowest target is $65 and the highest is $129.

Price Target: $88.77 (-0.66%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$65	$88.77	$92	$129
Change	-27.26%	-0.66%	+2.95%	+44.36%

Analyst Ratings

The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	6	7	8	8	8	8
Buy	3	4	4	4	4	5
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	12	12	12	12	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Faisal Khurshid Leerink Partners	Leerink Partners	Buy Maintains $88 → $102	Buy	Maintains	$88 → $102	+14.15%	Jul 10, 2025
Leland Gershell Oppenheimer	Oppenheimer	Buy Maintains $76 → $110	Buy	Maintains	$76 → $110	+23.10%	Jul 10, 2025
Tazeen Ahmad B of A Securities	B of A Securities	Strong Buy Maintains $73 → $95	Strong Buy	Maintains	$73 → $95	+6.31%	Jul 10, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $91 → $129	Buy	Maintains	$91 → $129	+44.36%	Jul 10, 2025
Joseph Stringer Needham	Needham	Strong Buy Maintains $72 → $95	Strong Buy	Maintains	$72 → $95	+6.31%	Jul 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

179.00M

Increased by 37.56%

from 130.13M

Revenue Next Year

313.24M

Increased by 74.99%

from 179.00M

EPS This Year

-2.76

from -4.34

EPS Next Year

-1.45

from -2.76

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	3.15M	23.64M	77.43M	130.13M	179.00M	313.24M	563.20M
Revenue Growth	-	-	649.46%	227.56%	68.06%	37.56%	74.99%	79.80%
EPS	-3.04	-1.40	-3.47	-3.20	-4.34	-2.76	-1.45	1.86
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	48.05
No. Analysts	-	-	-	-	-	14	14	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	191.5M	420.0M	686.8M
Avg	179.0M	313.2M	563.2M
Low	166.6M	226.8M	420.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	47.1%	134.6%	119.3%
Avg	37.6%	75.0%	79.8%
Low	28.0%	26.7%	34.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.44	-0.23	3.16
Avg	-2.76	-1.45	1.86
Low	-3.18	-2.50	0.90

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.